Moderna
Biotech

FDA accepts filing for Moderna flu vaccine after swift rethink

The FDA has accepted Moderna’s revised influenza vaccine filing, putting the biotech on track to win approval before the 2026-27 flu season.
Nick Paul Taylor Feb 18, 2026 9:21am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Novartis finds natural partnership in macrocycle biotech

Feb 18, 2026 10:13am
Blue snowshoes stuck in the snow in front of a forest

Korsana crosses into crowded Alzheimer's field with $175M

Feb 18, 2026 6:00am
Businesspeople reaching agreement

GSK inks 5-year deal with Jackson Lab for neuro research

Feb 18, 2026 3:30pm
Pediatrician pretending to listen to heartbeat of teddy bear with baby and mother watching

Blood from pediatricians yields new antiviral antibodies

Feb 18, 2026 2:15pm
Bill Cassidy and RFK Jr
Favicon Fierce Pharma

Sen. Cassidy offers proposals to reshape FDA

Feb 18, 2026 11:45am
More News

Rasayana Tx ingests GI candidate in $36M deal

Feb 18, 2026 10:40am

Sensei steps back from brink by finding Faeth merger

Feb 18, 2026 10:33am

Fierce Biotech Fundraising Tracker '26: Korsana, ILiAD & more

Feb 18, 2026 9:30am

Preclinical eye disease biotech sets sights on $17M NYSE IPO

Feb 18, 2026 8:55am